AbCellera Biologics Inc. SEC filings ABCL
AbCellera Biologics Inc. has 322 filings in SEC EDGAR's recent list, going back to Apr 6, 2017. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 11, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2022 | — |
| CORRESP | Letter to the SEC | Jul 22, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2022 | — |
| EFFECT | Filing | Jun 21, 2021 | — |
| CORRESP | Letter to the SEC | Jun 17, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 16, 2021 | — |
| CERT | Filing | Dec 11, 2020 | — |
| EFFECT | Filing | Dec 10, 2020 | — |
| SEC STAFF LETTER | Filing | Dec 10, 2020 | — |
| 8-A12B | Filing | Dec 8, 2020 | — |
| CORRESP | Letter to the SEC | Dec 8, 2020 | — |
| CORRESP | Letter to the SEC | Dec 8, 2020 | — |
| CORRESP | Letter to the SEC | Dec 3, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 2, 2020 | — |
| CORRESP | Letter to the SEC | Nov 30, 2020 | — |
| CORRESP | Letter to the SEC | Nov 20, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2020 | — |
| SEC STAFF LETTER | Filing | Nov 12, 2020 | — |
| DRSLTR | Filing | Nov 6, 2020 | — |
| DRS/A | Filing | Nov 6, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 2, 2020 | — |
| DRS | Filing | Oct 5, 2020 | — |
| D | Filing | May 27, 2020 | — |
| D | Filing | Aug 10, 2018 | — |
| D | Filing | Mar 19, 2018 | — |
| D | Filing | Apr 6, 2017 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABCL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver, British Columbia, Canada
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1703057
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.